1N9 Stock Overview
Develops and markets nutraceutical products in Canada, Germany, and Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NeutriSci International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.01 |
| 52 Week Low | CA$0.0005 |
| Beta | 0.84 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -99.33% |
| 5 Year Change | -98.66% |
| Change since IPO | -99.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1N9 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | 0.5% |
| 1Y | 0% | -7.1% | 7.2% |
Return vs Industry: 1N9 underperformed the German Personal Products industry which returned 3.6% over the past year.
Return vs Market: 1N9 exceeded the German Market which returned -1.3% over the past year.
Price Volatility
| 1N9 volatility | |
|---|---|
| 1N9 Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1N9's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 1N9's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Glen Rehman | www.neutrisci.com |
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets.
NeutriSci International Inc. Fundamentals Summary
| 1N9 fundamental statistics | |
|---|---|
| Market cap | €589.65k |
| Earnings (TTM) | -€365.14k |
| Revenue (TTM) | €39.65k |
14.9x
P/S Ratio-1.6x
P/E RatioIs 1N9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1N9 income statement (TTM) | |
|---|---|
| Revenue | CA$59.98k |
| Cost of Revenue | CA$145.85k |
| Gross Profit | -CA$85.86k |
| Other Expenses | CA$466.59k |
| Earnings | -CA$552.45k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0031 |
| Gross Margin | -143.15% |
| Net Profit Margin | -921.00% |
| Debt/Equity Ratio | -23.2% |
How did 1N9 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/05 05:41 |
| End of Day Share Price | 2024/05/08 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeutriSci International Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|